Literature DB >> 23975651

Effect of melatonin supplementation and cross-fostering on renal glutathione system and development of hypertension in spontaneously hypertensive rats.

Lee Siew-Keah1, Arunkumar Sundaram, K N S Sirajudeen, Rahimah Zakaria, H J Singh.   

Abstract

Antenatal and postnatal environments are hypothesised to influence the development of hypertension. This study investigates the synergistic effect of cross-fostering and melatonin supplementation on the development of hypertension and renal glutathione system in spontaneously hypertensive rats (SHR). In one experiment, 1-day-old male SHR pups were fostered to either SHR (shr-SHR) or Wistar-Kyoto rats, (shr-WKY). In a concurrent experiment, SHR dams were given melatonin in drinking water (10 mg/kg body weight) from day 1 of pregnancy. Immediately following delivery, 1-day-old male pups were fostered either to SHR (Mel-shr-SHR) or WKY (Mel-shr-WKY) dams receiving melatonin supplementation until weaning on day 21. Upon weaning, melatonin supplementation was continued to these pups until the age of 16 weeks. Systolic blood pressures (SBP) were recorded at the age of 4, 6, 8, 12 and 16 weeks. Renal antioxidant activities were measured. Mean SBP of shr-WKY, Mel-shr-SHR and Mel-shr-WKY was significantly lower than that in shr-SHR until the age of 8 weeks. At 12 and 16 weeks of age, mean SBP of Mel-shr-WKY was lower than those in non-treated shr-SHR and shr-WKY pups but was not significantly different from that in Mel-shr-SHR. Renal glutathione peroxidase (GPx) and glutathione S-transferase (GST) activities were significantly higher in Mel-shr-SHR and Mel-shr-WKY at 16 weeks of age. It appears that combination of cross-fostering and melatonin supplementation exerts no synergistic effect on delaying the rise in blood pressure in SHR. The elevated GPx and GST activities are likely to be due to the effect of melatonin supplementation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23975651     DOI: 10.1007/s13105-013-0282-3

Source DB:  PubMed          Journal:  J Physiol Biochem        ISSN: 1138-7548            Impact factor:   4.158


  26 in total

1.  Maternal nursing behaviour and the delivery of milk to the neonatal spontaneously hypertensive rat.

Authors:  I Gouldsborough; V Black; I T Johnson; N Ashton
Journal:  Acta Physiol Scand       Date:  1998-01

Review 2.  Ontogenetic aspects of hypertension development: analysis in the rat.

Authors:  J Zicha; J Kunes
Journal:  Physiol Rev       Date:  1999-10       Impact factor: 37.312

3.  Effects of antenatal, postpartum and post-weaning melatonin supplementation on blood pressure and renal antioxidant enzyme activities in spontaneously hypertensive rats.

Authors:  S K Lee; K N S Sirajudeen; Arunkumar Sundaram; Rahimah Zakaria; H J Singh
Journal:  J Physiol Biochem       Date:  2011-01-06       Impact factor: 4.158

4.  Relative contribution of the prenatal versus postnatal period on development of hypertension and growth rate of the spontaneously hypertensive rat.

Authors:  Robert Di Nicolantonio; Kathy Koutsis; Kerryn T Westcott; Mary E Wlodek
Journal:  Clin Exp Pharmacol Physiol       Date:  2006 Jan-Feb       Impact factor: 2.557

5.  Effect of melatonin on changes in hepatic antioxidant enzyme activities in rats treated with alpha-naphthylisothiocyanate.

Authors:  Y Ohta; M Kongo; T Kishikawa
Journal:  J Pineal Res       Date:  2001-11       Impact factor: 13.007

6.  Up-regulation of kidney NAD(P)H oxidase and calcineurin in SHR: reversal by lifelong antioxidant supplementation.

Authors:  Chang-De Zhan; Ram K Sindhu; Nosratola D Vaziri
Journal:  Kidney Int       Date:  2004-01       Impact factor: 10.612

7.  Renal and vascular glutathione S-transferase mu is not affected by pharmacological intervention to reduce systolic blood pressure.

Authors:  Han Hui Caline Koh-Tan; Delyth Graham; Carlene A Hamilton; Gavin Nicoll; Laura Fields; Martin W McBride; Barbara Young; Anna F Dominiczak
Journal:  J Hypertens       Date:  2009-08       Impact factor: 4.844

8.  Melatonin reduces renal interstitial inflammation and improves hypertension in spontaneously hypertensive rats.

Authors:  Mayerly Nava; Yasmir Quiroz; Nosratola Vaziri; Bernardo Rodriguez-Iturbe
Journal:  Am J Physiol Renal Physiol       Date:  2002-11-19

9.  Assessment of DNA oxidation and antioxidant activity in hypertensive patients with chronic kidney disease.

Authors:  Yildiz Dincer; Nigar Sekercioglu; Meltem Pekpak; Kezban N Gunes; Tulay Akcay
Journal:  Ren Fail       Date:  2008       Impact factor: 2.606

10.  Antioxidant enzymes--superoxide dismutase and glutathione peroxidase--in haemodialyzed patients.

Authors:  T Zima; S Stípek; J Crkovská; K Nĕmecek; J Pláteník; V Bártová; V Tesar
Journal:  Blood Purif       Date:  1996       Impact factor: 2.614

View more
  2 in total

1.  Circadian alignment in a foster mother improves the offspring's pathological phenotype.

Authors:  Lucie Olejníková; Lenka Polidarová; Michal Behuliak; Martin Sládek; Alena Sumová
Journal:  J Physiol       Date:  2018-05-10       Impact factor: 5.182

2.  Association of GSTM1 and GSTT1 gene polymorphisms with COVID-19 susceptibility and its outcome.

Authors:  Mohammad Abbas; Sushma Verma; Shrikant Verma; Sahabjada Siddiqui; Faizan H Khan; Syed T Raza; Zeba Siddiqi; Ale Eba; Farzana Mahdi
Journal:  J Med Virol       Date:  2021-06-12       Impact factor: 20.693

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.